---
title: "Nuvectis Pharma (NVCT.US) — 財務報表"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/NVCT.US/norm.md"
symbol: "NVCT.US"
name: "Nuvectis Pharma"
parent: "https://longbridge.com/zh-HK/quote/NVCT.US.md"
datetime: "2026-03-09T08:48:06.987Z"
locales:
  - [en](https://longbridge.com/en/quote/NVCT.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/NVCT.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/NVCT.US/norm.md)
---

> 支持的語言: [English](https://longbridge.com/en/quote/NVCT.US/norm.md) | [简体中文](https://longbridge.com/zh-CN/quote/NVCT.US/norm.md)


# Nuvectis Pharma (NVCT.US) — 財務報表

## 損益表 (USD)

| 指標 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.3153 | -0.4354 | -0.2964 | -0.2674 | -0.3518 |
| ROE | -137.92% | -193.55% | -133.96% | -139.09% | -241.42% |
| 營業收入 | - | - | - | - | - |
| 凈利潤 | -7.31M | -9.89M | -6.33M | -5.33M | -6.25M |
| 營業利潤 | -7.62M | -7.79M | -6.59M | -5.57M | -6.45M |
| 毛利率 | - | - | - | - | - |
| 凈利率 | - | - | - | - | - |
| 利潤含金量 | - | - | - | - | - |

## 資產負債表 (USD)

| 指標 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| 資產與負債 | 31.71M | 35.59M | 27.01M | 30.15M | 18.61M |
| 權益乘數 | 1.72 | 1.48 | 1.60 | 1.44 | 1.92 |
| 每股凈資產 | 0.7171 | 0.9364 | 0.7066 | 0.8866 | 0.4982 |
| 資產周轉率 | - | - | - | - | - |
| 現金及短投 | 31.63M | 35.44M | 26.79M | 29.86M | 18.53M |
| 存貨與應收 | - | - | - | - | - |
| 長期投資 | - | - | - | - | - |
| 凈債務 | -31.63M | -35.44M | -26.79M | -29.86M | -18.53M |

## 現金流量表 (USD)

| 指標 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| 經營現金流 | -3.97M | -4.49M | -3.37M | -4.17M | -2.46M |
| 投資現金流 | - | - | - | - | - |
| 融資現金流 | 166000.00 | 13.14M | 296000.00 | 15.51M | 3.83M |
| 自由現金流 | -1.53M | -1.86M | -1.31M | -1.99M | -205625.00 |
| 現金流充裕率 | - | - | - | - | - |
| 舉債與償債 | - | - | - | - | - |
| 資本支出 | - | - | - | - | - |